Immunogenicity and safety of a two‐dose live attenuated varicella vaccine given to adults following autologous hematopoietic stem cell transplantation - Concepedia

Concepedia

Publication | Open Access

Immunogenicity and safety of a two‐dose live attenuated varicella vaccine given to adults following autologous hematopoietic stem cell transplantation

DOI Full Paper Access

24

Citations

10

References

2014

Year

Joe Sasadeusz, H. Miles Prince, AP Schwarer, Jeff Szer, A Stork, H.L. Bock, Michael Povey, Ouzama Nicholson, Bruce L. Innis

Transplant Infectious Disease

Abstract

Oka-RIT was poorly immunogenic but safe when given to adults up to 6 months post autologous HSCT, and alternative strategies are required to prevent VZV-associated complications in these populations.

References

	Year	Citations

Page 1